Description
Product overview
CJC-1295 without DAC 5mg with Ipamorelin 5mg is a two-component research blend supplied for controlled laboratory investigation of GHRH- and secretagogue-related signaling models.
Ipamorelin + CJC-1295 research context
- Combines CJC-1295 without DAC and Ipamorelin in one research blend.
- Used in laboratory models examining receptor signaling and downstream endocrine pathway responses.
- Supports comparative research when preparation, timing and assay conditions are standardized.
Research applications
Suitable for receptor and pathway-focused assays, comparative peptide studies, model development and controlled time-course or concentration-response experiments involving the listed components.
Related research products
Researchers comparing GHRH-related peptide models can also review TH9507 GHRH Analog Peptide, 44aa and Tri-Receptor Agonist Peptide, 39aa.
Documentation and handling
Review available lot documentation and product specifications before use. Handle according to established laboratory procedures and protect the material from conditions that could compromise sample integrity.
For laboratory research purposes only. Not for human or veterinary consumption.
